The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

In patients with aortic and/or mitral valve disease the presence of pulmonary hypertension
(PH) indicates a decompensated state of the disease with left ventricular and left atrial …

In the summer of 2016, delegates from the German Society of Cardiology (DGK), the
German Respiratory Society (DGP), and the German Society of Pediatric Cardiology (DGPK) …

Pulmonary hypertension (PH) is a risk factor for morbidity and mortality in patients
undergoing surgery and anesthesia. This document represents the first international …

Objective The study objective was to evaluate the perioperative and long-term outcomes of
aortic root repair and aortic root replacement and provide evidence for root management in …

Left heart disease (LHD) is the most common cause of pulmonary hypertension (PH), which
may be classified further as isolated post-capillary (ipcPH) or combined post-and pre …

Objective To compare perioperative and long-term outcomes in patients undergoing
hemiarch and aggressive arch replacement for acute type A aortic dissection (ATAAD) …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

BACKGROUND: Current guidelines recommend intervention for asymptomatic rheumatic
mitral stenosis (MS) with mitral valve area≤ 1.5 cm2 based on indicators including …